Abstract
Background
Many patients with advanced cancer receive aggressive chemotherapy close to death and are referred too late to palliative or hospice care.
Aim
The aim of this study was to investigate oncologists’ and oncology nurses’ perceptions of the optimal timing for discussions about forgoing cancer-specific therapy at the End-of-Life (EOL) and the reasons that might hinder them.
Design
Qualitative in-depth interviews with oncologists and oncology nurses were carried out. The empirical data were evaluated from a normative perspective.
Setting/participants
Twenty-nine physicians and nurses working at the Department of Hematology and Oncology of a German university hospital were interviewed.
Results
Health-care professionals differed considerably in their understanding of when to initiate discussions about forgoing cancer-specific therapy at the EOL. However, their views could be consolidated into three approaches: (1) preparing patients gradually throughout the course of disease (anticipatory approach) which is best suited to empower patient self-determination in decision-making, (2) waiting until the patient him/herself starts the discussion about forgoing cancer-specific treatment, and (3) waiting until all tumor-specific therapeutic options are exhausted.
Conclusion
The empirically informed ethical analysis clearly favors an approach that prepares patients for forgoing cancer-specific therapy throughout the course of disease. Since the last two approaches often preclude advance care planning, these approaches may be less ethically acceptable. The proposed framework could serve as a starting point for the development of concrete recommendations on the optimal timing for EOL discussions.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Russell BJ, Ward AM (2011) Deciding what information is necessary: do patients with advanced cancer want to know all the details? Cancer Manag Res 3:191–199
Back AL, Michaelsen K, Alexander S et al (2010) How oncology fellows discuss transitions in goals of care: a snapshot of approaches used prior to training. J Palliat Med 13:395–400
Wright AA, Zhang B, Ray A et al (2008) Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA 300:1665–1673
Gordon EJ, Daugherty CK (2003) ‘Hitting you over the head’: oncologists’ disclosure of prognosis to advanced cancer patients. Bioethics 17:142–168
Matsuyama R, Reddy S, Smith TJ (2006) Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer. J Clin Oncol 24:3490–3496
Snyder S, Hazelett S, Allen K, Radwany S (2013) Physician knowledge, attitude, and experience with advance care planning, palliative care, and hospice: results of a primary care survey. Am J Hosp Palliat Care 30:419–424
Hui D, Mori M, Parsons HA et al (2012) The lack of standard definitions in the supportive and palliative oncology literature. J Pain Symptom Manage 43:582–592
Gaertner J, Wolf J, Voltz R (2012) Early palliative care for patients with metastatic cancer. Curr Opin Oncol 24:357–362
Curtis JR, Patrick DL, Caldwell ES, Collier AC (2000) Why don’t patients and physicians talk about end-of-life care? Barriers to communication for patients with acquired immunodeficiency syndrome and their primary care clinicians. Arch Intern Med 160:1690–1696
Kissane DW, Bylund CL, Banerjee SC et al (2012) Communication skills training for oncology professionals. J Clin Oncol 30:1242–1247
Brown RF, Bylund CL (2008) Communication skills training: describing a new conceptual model. Acad Med 83:37–44
Hagerty RG, Butow PN, Ellis PA et al (2004) Cancer patient preferences for communication of prognosis in the metastatic setting. J Clin Oncol 22:1721–1730
Clayton JM, Hancock K, Parker S et al (2008) Sustaining hope when communicating with terminally ill patients and their families: a systematic review. Psychooncology 17:641–659
Butow PN, Dowsett S, Hagerty R, Tattersall MH (2002) Communicating prognosis to patients with metastatic disease: what do they really want to know? Support Care Cancer 10:161–168
Schofield PE, Beeney LJ, Thompson JF et al (2001) Hearing the bad news of a cancer diagnosis: the Australian melanoma patient’s perspective. Ann Oncol 12:365–371
Clayton JM, Butow PN, Tattersall MH (2005) When and how to initiate discussion about prognosis and end-of-life issues with terminally ill patients. J Pain Symptom Manage 30:132–144
Keating NL, Landrum MB, Rogers SO Jr et al (2010) Physician factors associated with discussions about end-of-life care. Cancer 116:998–1006
Schofield P, Carey M, Love A et al (2006) ‘Would you like to talk about your future treatment options’? Discussing the transition from curative cancer treatment to palliative care. Palliat Med 20:397–406
Quill TE (2000) Perspectives on care at the close of life. Initiating end-of-life discussions with seriously ill patients: addressing the “elephant in the room”. JAMA 284:2502–2507
Gott M, Ingleton C, Bennett MI, Gardiner C (2011) Transitions to palliative care in acute hospitals in England: qualitative study. BMJ 342:d1773
Friedman BT, Harwood MK, Shields M (2002) Barriers and enablers to hospice referrals: an expert overview. J Palliat Med 5:73–84
Coyne IT (1997) Sampling in qualitative research. Purposeful and theoretical sampling; merging or clear boundaries? J Adv Nurs 26:623–630
Glaser BG, Strauss AL (1967) The discovery of grounded theory: strategies for qualitative research. de Gruyter, New York
Charmaz K (2010) Constructing grounded theory: a practical guide through qualitative analysis. Los Angeles, Calif. [u.a.]: Sage
Beauchamp TL, Childress JF (2009) Principles of biomedical ethics. Oxford University Press, Incorporated
Mack JW, Smith TJ (2012) Reasons why physicians do not have discussions about poor prognosis, why it matters, and what can be improved. J Clin Oncol 30:2715–2717
Leydon GM, Boulton M, Moynihan C et al (2000) Cancer patients’ information needs and information seeking behaviour: in depth interview study. BMJ 320:909–913
Fried TR, Bradley EH, O’Leary J (2003) Prognosis communication in serious illness: perceptions of older patients, caregivers, and clinicians. J Am Geriatr Soc 51:1398–1403
Voogt E, van der Heide A, Rietjens JA et al (2005) Attitudes of patients with incurable cancer toward medical treatment in the last phase of life. J Clin Oncol 23:2012–2019
Winkler EC, Reiter-Theil S, Lange-Riess D et al (2009) Patient involvement in decisions to limit treatment: the crucial role of agreement between physician and patient. J Clin Oncol 27:2225–2230
Temel JS, Greer JA, Muzikansky A et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363:733–742
Acknowledgements
This work was supported by research grant no. 109658 of the Deutsche Krebshilfe (German Cancer Aid). We thank Dr. Carola Christ for the administrative support and all the participants interviewed for this study. We wish to thank our anonymous reviewers for their helpful comments.
Conflict of interest
No competing financial interests exist.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Laryionava, K., Heußner, P., Hiddemann, W. et al. Framework for timing of the discussion about forgoing cancer-specific treatment based on a qualitative study with oncologists. Support Care Cancer 23, 715–721 (2015). https://doi.org/10.1007/s00520-014-2416-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-014-2416-8